■ The glaucoma surgical device market is expected to grow at a rate of nearly 23% over the next 5 years, according to a Market Scope report. The market is expected to grow to nearly $1.7 billion by 2023, up from a small base of just under $634 million in 2018.
Minimally invasive glaucoma surgery (MIGS) drainage implants are safe and increasingly effective for all stages of glaucoma, and they will significantly expand the role of surgery over the next 5 years, but product improvements are also expected in diagnostic devices, pharmaceuticals, lasers, and other surgical devices.
Venture capital firms have invested more than $500 million in MIGS implants in the United States. Market Scope expects the number and variety of available MIGS stents to grow over the next several years.